Jazz Pharmaceuticals plc (JAZZ) is a specialty biopharmaceutical company focused on neuroscience and oncology. Its stock recently completed an approximately 50% retracement of the prior advance and a successful test of trend support at the 50-day moving average. A higher swing low resulted, along with the formation of a bullish flag pattern, a trend continuation setup. The combination of a retracement level combined with a moving average, strengthens the significance of that low.
The formation of a bull flag pattern followed the recent breakout of a long-term basing pattern, with a breakout above the 2015 high of $194.73 triggering in April and a subsequent advance that eventually reached a new high of $243.32 in May. That led to a pullback and the formation of the flag consolidation pattern. An upside breakout of the flag triggered on Tuesday and it was confirmed with a daily close at $243.47, above the May high.
A strong new high closing price sets the stage for a continuation of the long-term bull trend, with a new leg up. Given the larger bullish indications – a long-term base breakout followed by a constructive advance – another decisive advance may follow the new flag breakout. Notably, a long-term base breakout can be the beginning of a healthy sustained advance. Given the behavior of JAZZ so far, that remains the most likely scenario.
Since the 50-day moving average has clearly been recognized as trend support, that indicator continues to be key going forward. Moreover, following a decisive new bull flag breakout, the 20-day moving average should take precedence, as momentum continues to improve. When the longer pattern lines up with the shorter pattern, the probability of follow-through increases significantly.
If you’d like to know more about technical analysis and how traders use it, please visit our educational area.
With over 20 years of experience in financial markets, Bruce is a seasoned finance MBA and CMT® charter holder. Having worked as head of trading strategy at hedge funds and a corporate advisor for trading firms, Bruce shares his expertise in futures to retail investors, providing actionable insights through both technical and fundamental analyses.